Placeholder Banner

BIO Asia 2016 Will Feature Insights Into the Japanese Biotech Market

December 23, 2015
The 2016 BIO Asia International Conference, happening March 15-16 in Tokyo, brings together the global biotechnology and pharmaceutical industries to explore licensing and research collaborations in the current Asia-Pacific business and policy environments. Attendees will gain insights into the changes, challenges, and opportunities key opinion and policy leaders foresee for the Japanese biotech market. Learn more & register here.

Programming at BIO Asia 2016

This year's conference will feature programming on a variety of key topics, including:

  • Implications of the Trans-Pacific Partnership and Other Biopharma Policy Developments

  • Conducting Global Clinical Trials: Critical Success Factors to Accelerate Approvals

  • Lessons from Regenerative Medicine Reforms’ Early Beneficiaries

  • Biotechnology’s Role in Promoting Healthy Aging in a ME-BYO Context

  • Vaccine Programs as Cross-Border Deal Catalysts

  • Trans-Pacific Industry/University Collaborations

  • Market Outlook—Regional Cross-Licensing Trends and Growth Potential

For details about these program topics, click here.

Keynote Speeches from Industry Leaders

The conference will also feature keynote speeches from top industry officials, including:

  • Dr. Tatsuya Kondo
    Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA) Japan

  • Dr. Makoto Suematsu
    President, Japan Agency for Medical Research and Development

  • Christophe Weber
    Representative Director, President & CEO, Takeda

Networking Opportunities

Last year's conference attendees represented 25 countries, and held more than 800 One-on-One Partnering meetings:

Register By January 22nd & Save On Registration Fees

The early bird discount deadline in January, 22, 2016. Register before then to save on registration fees.  Learn more & register here.